ArticleBMC cancer2024

A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.

P Travis Courtney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.